Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
New England Journal of Medicine, Volume 372, Issue 17, Page 1670-1671, April 2015.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app